JP2024507788A5 - - Google Patents
Info
- Publication number
- JP2024507788A5 JP2024507788A5 JP2023548941A JP2023548941A JP2024507788A5 JP 2024507788 A5 JP2024507788 A5 JP 2024507788A5 JP 2023548941 A JP2023548941 A JP 2023548941A JP 2023548941 A JP2023548941 A JP 2023548941A JP 2024507788 A5 JP2024507788 A5 JP 2024507788A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- compound according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149927P | 2021-02-16 | 2021-02-16 | |
| US63/149,927 | 2021-02-16 | ||
| PCT/US2022/016261 WO2022177840A1 (en) | 2021-02-16 | 2022-02-14 | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507788A JP2024507788A (ja) | 2024-02-21 |
| JP2024507788A5 true JP2024507788A5 (cg-RX-API-DMAC7.html) | 2025-02-13 |
Family
ID=80625127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548941A Pending JP2024507788A (ja) | 2021-02-16 | 2022-02-14 | Hivインテグラーゼ阻害剤として有用な四環式複素環化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11958864B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4294813B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024507788A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230147131A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117083282B (cg-RX-API-DMAC7.html) |
| AR (1) | AR124868A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022223241B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3208396A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3048138T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023009445A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202246286A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022177840A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240151256A (ko) | 2019-03-22 | 2024-10-17 | 길리애드 사이언시즈, 인코포레이티드 | 가교된 트리시클릭 카르바모일피리돈 화합물 및 그의 제약 용도 |
| EP4110783A1 (en) | 2020-02-24 | 2023-01-04 | Gilead Sciences, Inc. | Tetracyclic compounds for treating hiv infection |
| CN116390924B (zh) | 2020-09-30 | 2025-11-07 | 吉利德科学公司 | 桥连三环氨基甲酰基吡啶酮化合物及其用途 |
| CR20260070A (es) | 2021-01-19 | 2026-04-24 | Gilead Sciences Inc | COMPUESTOS DE PIRIDOTRIAZINA SUSTITUIDOS Y USOS DE ESTOS (Divisional 2023-0315) |
| TWI856796B (zh) | 2022-04-06 | 2024-09-21 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
| WO2024226485A1 (en) * | 2023-04-28 | 2024-10-31 | Merck Sharp & Dohme Llc | Delivery devices for anti-hiv compounds |
| WO2026101812A1 (en) * | 2024-11-07 | 2026-05-15 | Merck Sharp & Dohme Llc | Hiv integrase inhibitors for treatment of hiv infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2660239B1 (en) * | 2008-07-25 | 2016-11-23 | VIIV Healthcare Company | Chemical compounds as synthetic intermediates |
| WO2010011812A1 (en) * | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| ES2395705T3 (es) * | 2008-07-25 | 2013-02-14 | Glaxosmithkline Llc | Compuestos químicos |
| LT2620436T (lt) * | 2010-09-24 | 2018-08-10 | Shionogi & Co., Ltd. | Pakeistojo policiklinio karbamoilpiridono darinio provaistas |
| WO2017113288A1 (en) * | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
| WO2018140368A1 (en) * | 2017-01-26 | 2018-08-02 | Merck Sharp & Dohme Corp. | Substituted quinolizine derivatives useful as hiv integrase inhibitors |
-
2022
- 2022-02-14 US US17/670,689 patent/US11958864B2/en active Active
- 2022-02-14 CA CA3208396A patent/CA3208396A1/en active Pending
- 2022-02-14 AU AU2022223241A patent/AU2022223241B2/en active Active
- 2022-02-14 MX MX2023009445A patent/MX2023009445A/es unknown
- 2022-02-14 EP EP22707560.3A patent/EP4294813B1/en active Active
- 2022-02-14 AR ARP220100289A patent/AR124868A1/es unknown
- 2022-02-14 CN CN202280022034.3A patent/CN117083282B/zh active Active
- 2022-02-14 ES ES22707560T patent/ES3048138T3/es active Active
- 2022-02-14 TW TW111105302A patent/TW202246286A/zh unknown
- 2022-02-14 KR KR1020237031339A patent/KR20230147131A/ko active Pending
- 2022-02-14 JP JP2023548941A patent/JP2024507788A/ja active Pending
- 2022-02-14 WO PCT/US2022/016261 patent/WO2022177840A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5562255B2 (ja) | ウイルス感染を治療する方法 | |
| JP2004509061A5 (cg-RX-API-DMAC7.html) | ||
| CN101743004A (zh) | 治疗用组合物及其用途 | |
| JP2009535352A5 (cg-RX-API-DMAC7.html) | ||
| EP3356355B1 (en) | Compounds and combinations for the treatment of hiv | |
| CN1758905A (zh) | 青蒿素在治疗致癌病毒诱导的肿瘤和治疗病毒感染中的应用 | |
| JP2020500866A5 (cg-RX-API-DMAC7.html) | ||
| CN111867582A (zh) | 衣壳组装调节剂给药方案 | |
| JP2009525265A5 (cg-RX-API-DMAC7.html) | ||
| JP4627356B2 (ja) | ウイルス性心筋炎の予防または治療薬剤 | |
| TW202617156A (zh) | 用於治療進行性纖維化間質性肺病之新穎口服醫藥組合物及劑量療法 | |
| JP2000517323A (ja) | B型肝炎およびレトロウイルス関連疾患の治療のためのジカフェオイルキナ酸の新規使用および新規カフェオイルキナ酸誘導体 | |
| NZ541187A (en) | Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) with an inhibitor of cytochrome P450, such as protease inhibitors | |
| US5179096A (en) | Therapeutic application of flouroquinolone derivatives | |
| JP2002528508A (ja) | B型肝炎治療のための組合せ療法 | |
| WO2015120057A1 (en) | Pharmaceutical combinations against co-infection with hiv and tuberculosis | |
| AU2018239257B2 (en) | HIV post-exposure prophylaxis | |
| US6441009B1 (en) | Agent and method of preventing and treating heavy metal exposure and toxicity | |
| CN114051411B (zh) | Eyp001与ifn用于治疗hbv感染的协同效应 | |
| US5432187A (en) | Benzimidazole anthelmintic in the treatment of microsporidial infections | |
| JP2007516296A5 (cg-RX-API-DMAC7.html) | ||
| RU2023123879A (ru) | Тетрациклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич | |
| WO2011046901A2 (en) | Broad spectrum antiviral and methods of use | |
| US20220265689A1 (en) | Hiv pre-exposure prophylaxis | |
| CA3054822C (en) | Hiv post-exposure prophylaxis |